Litcius/Paper detail

Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial

Atte Meretoja, Nawaf Yassi, Teddy Y. Wu, Leonid Churilov, Gerli Sibolt, Jiann‐Shing Jeng, Timothy Kleinig, Neil J. Spratt, Vincent Thijs, Tissa Wijeratne, Der‐Yang Cho, Darshan Shah, Geoffrey Cloud, Thanh G. Phan, Christopher Bladin, Andrew Moey, Richard I. Aviv, Christen Barras, Gagan Sharma, Chung Y. Hsu, Henry Ma, Bruce Campbell, Peter Mitchell, Bernard Yan, Mark Parsons, Marjaana Tiainen, Sami Curtze, Daniel Strbian, Sung‐Chun Tang, Jackson Harvey, Christopher Levi, Geoffrey A. Donnan, Stephen M. Davis

2020The Lancet Neurology144 citationsDOI

Topics & Concepts

MedicineTranexamic acidIntracerebral hemorrhageGlasgow Coma ScalePlaceboStroke (engine)Randomized controlled trialPopulationSurgeryAnesthesiaAlternative medicineBlood lossPathologyMechanical engineeringEnvironmental healthEngineeringIntracerebral and Subarachnoid Hemorrhage ResearchBlood transfusion and managementAcute Ischemic Stroke Management
Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial | Litcius